536 related articles for article (PubMed ID: 27106296)
41. Outcome study of first-episode psychosis. I: Relapse rates after 1 year.
Rabiner CJ; Wegner JT; Kane JM
Am J Psychiatry; 1986 Sep; 143(9):1155-8. PubMed ID: 2875663
[TBL] [Abstract][Full Text] [Related]
42. Definitions of relapse in trials comparing antipsychotic maintenance with discontinuation or reduction for schizophrenia spectrum disorders: A systematic review.
Moncrieff J; Crellin NE; Long MA; Cooper RE; Stockmann T
Schizophr Res; 2020 Nov; 225():47-54. PubMed ID: 31604607
[TBL] [Abstract][Full Text] [Related]
43. Does relapse contribute to treatment resistance? Antipsychotic response in first- vs. second-episode schizophrenia.
Takeuchi H; Siu C; Remington G; Fervaha G; Zipursky RB; Foussias G; Agid O
Neuropsychopharmacology; 2019 May; 44(6):1036-1042. PubMed ID: 30514883
[TBL] [Abstract][Full Text] [Related]
44. Medication-adherent first-episode psychosis patients also relapse: why?
Levy E; Pawliuk N; Joober R; Abadi S; Malla A
Can J Psychiatry; 2012 Feb; 57(2):78-84. PubMed ID: 22340147
[TBL] [Abstract][Full Text] [Related]
45. When to initiate antipsychotic treatment for psychotic symptoms: At the premorbid phase or first episode of psychosis?
Zhang T; Xu L; Wei Y; Tang X; Hu Y; Cui H; Tang Y; Xie B; Li C; Wang J
Aust N Z J Psychiatry; 2021 Mar; 55(3):314-323. PubMed ID: 33143440
[TBL] [Abstract][Full Text] [Related]
46. Second-generation antipsychotic discontinuation in first episode psychosis: an updated review.
Miller BJ; Bodenheimer C; Crittenden K
Clin Psychopharmacol Neurosci; 2011 Aug; 9(2):45-53. PubMed ID: 23429653
[TBL] [Abstract][Full Text] [Related]
47. Pharmacological management of first-episode schizophrenia and related nonaffective psychoses.
Bradford DW; Perkins DO; Lieberman JA
Drugs; 2003; 63(21):2265-83. PubMed ID: 14524730
[TBL] [Abstract][Full Text] [Related]
48. Trajectories after first-episode psychosis: Complement to ambiguous outcomes of long-term antipsychotic treatment by exploring a few hidden cases.
Liu CC; Lin YT; Liu CM; Hsieh MH; Chien YL; Hwang TJ; Hwu HG
Early Interv Psychiatry; 2019 Aug; 13(4):895-901. PubMed ID: 29927087
[TBL] [Abstract][Full Text] [Related]
49. Predictors for symptom re-exacerbation after targeted stepwise drug discontinuation in first-episode schizophrenia: Results of the first-episode study within the German research network on schizophrenia.
Gaebel W; Riesbeck M; Wölwer W; Klimke A; Eickhoff M; von Wilmsdorff M; de Millas W; Maier W; Ruhrmann S; Falkai P; Sauer H; Schmitt A; Riedel M; Klingberg S; Möller HJ
Schizophr Res; 2016 Jan; 170(1):168-76. PubMed ID: 26607102
[TBL] [Abstract][Full Text] [Related]
50. Predictors of relapse following response from a first episode of schizophrenia or schizoaffective disorder.
Robinson D; Woerner MG; Alvir JM; Bilder R; Goldman R; Geisler S; Koreen A; Sheitman B; Chakos M; Mayerhoff D; Lieberman JA
Arch Gen Psychiatry; 1999 Mar; 56(3):241-7. PubMed ID: 10078501
[TBL] [Abstract][Full Text] [Related]
51. Using antipsychotic agents in older patients.
Alexopoulos GS; Streim J; Carpenter D; Docherty JP;
J Clin Psychiatry; 2004; 65 Suppl 2():5-99; discussion 100-102; quiz 103-4. PubMed ID: 14994733
[TBL] [Abstract][Full Text] [Related]
52. The evaluation and treatment of first-episode psychosis.
Sheitman BB; Lee H; Strous R; Lieberman JA
Schizophr Bull; 1997; 23(4):653-61. PubMed ID: 9366001
[TBL] [Abstract][Full Text] [Related]
53. Remission and recovery during the first outpatient year of the early course of schizophrenia.
Ventura J; Subotnik KL; Guzik LH; Hellemann GS; Gitlin MJ; Wood RC; Nuechterlein KH
Schizophr Res; 2011 Oct; 132(1):18-23. PubMed ID: 21764563
[TBL] [Abstract][Full Text] [Related]
54. Reducing antipsychotic drugs in stable patients with chronic schizophrenia or schizoaffective disorder: a randomized controlled pilot trial.
Huhn M; Leucht C; Rothe P; Dold M; Heres S; Bornschein S; Schneider-Axmann T; Hasan A; Leucht S
Eur Arch Psychiatry Clin Neurosci; 2021 Mar; 271(2):293-302. PubMed ID: 32062728
[TBL] [Abstract][Full Text] [Related]
55. How long should antipsychotic treatment be continued after a single episode of schizophrenia?
Emsley R; Kilian S; Phahladira L
Curr Opin Psychiatry; 2016 May; 29(3):224-9. PubMed ID: 26967313
[TBL] [Abstract][Full Text] [Related]
56. Economic consequences of alternative medication strategies in first episode non-affective psychosis.
Stant AD; TenVergert EM; Wunderink L; Nienhuis FJ; Wiersma D
Eur Psychiatry; 2007 Sep; 22(6):347-53. PubMed ID: 17418538
[TBL] [Abstract][Full Text] [Related]
57. [First-episode schizophrenia: Pharmacotherapy and psychosocial interventions].
Garyfallos G
Psychiatriki; 2007 Jan; 18(1):29-46. PubMed ID: 22466428
[TBL] [Abstract][Full Text] [Related]
58. Achieving the Lowest Effective Antipsychotic Dose for Patients with Remitted Psychosis: A Proposed Guided Dose-Reduction Algorithm.
Liu CC; Takeuchi H
CNS Drugs; 2020 Feb; 34(2):117-126. PubMed ID: 31741178
[TBL] [Abstract][Full Text] [Related]
59. Medication strategies in first episode psychosis patients: A survey among psychiatrists.
Kikkert MJ; Veling W; de Haan L; Begemann MJH; de Koning M; ; Sommer IE
Early Interv Psychiatry; 2022 Feb; 16(2):139-146. PubMed ID: 33754470
[TBL] [Abstract][Full Text] [Related]
60. Predictors of clinical remission following a first episode of non-affective psychosis: sociodemographics, premorbid and clinical variables.
Díaz I; Pelayo-Terán JM; Pérez-Iglesias R; Mata I; Tabarés-Seisdedos R; Suárez-Pinilla P; Vázquez-Barquero JL; Crespo-Facorro B
Psychiatry Res; 2013 Apr; 206(2-3):181-7. PubMed ID: 23159063
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
